|
EPB41L5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66444635851803E-12 |
| Normal-vs-Stage2 |
3.55709994792619E-09 |
| Normal-vs-Stage3 |
1.12065912105663E-12 |
| Normal-vs-Stage4 |
6.88338275267597E-15 |
| Stage1-vs-Stage2 |
7.994000E-01 |
| Stage1-vs-Stage3 |
3.304400E-01 |
| Stage1-vs-Stage4 |
3.586900E-04 |
| Stage2-vs-Stage3 |
5.701400E-01 |
| Stage2-vs-Stage4 |
3.832100E-02 |
| Stage3-vs-Stage4 |
5.590300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.43929354282591E-14 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
5.81319999914953E-08 |
| Caucasian-vs-AfricanAmerican |
1.465780E-01 |
| Caucasian-vs-Asian |
1.953430E-01 |
| AfricanAmerican-vs-Asian |
1.691820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.76500003501445E-09 |
| Male-vs-Female |
4.905800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.82909243306995E-12 |
| Normal-vs-Extreme_Weight |
1.64779301314866E-12 |
| Normal-vs-Obese |
6.32827124036339E-15 |
| Normal-vs-Extreme_Obese |
1.45969999976181E-07 |
| Normal_Weight-vs-Extreme_Weight |
8.420000E-01 |
| Normal_Weight-vs-Obese |
6.947800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.593800E-01 |
| Extreme_Weight-vs-Obese |
5.197200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.982600E-01 |
| Obese-vs-Extreme_Obese |
9.319600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.57339738197038E-11 |
| Normal-vs-Age(41-60Yrs) |
2.64011035255862E-13 |
| Normal-vs-Age(61-80Yrs) |
1.63091762317435E-12 |
| Normal-vs-Age(81-100Yrs) |
5.109599998665E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.057600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.628400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.860000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.845600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.276600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.709200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
4.44089209850063E-15 |
| Normal-VS-KIRP CIMP |
8.75770000963172E-09 |
| Normal-VS-Unclassified PRCC |
4.33810000033397E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.606100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.220800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.519400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.262000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.981400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.223200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.18040030475208E-10 |
| Normal-vs-N2 |
3.80789999998576E-06 |
| N0-vs-N1 |
4.549600E-01 |
| N0-vs-N2 |
5.184400E-01 |
| N1-vs-N2 |
4.431400E-01 |
|
|
